The significant and growing global prevalence of diabetes continues to challenge people
with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal …

The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

Background Open-source automated insulin delivery (AID) systems are used by many
patients with type 1 diabetes. Data are needed on the efficacy and safety of an open-source …

Background Closed-loop control systems of insulin delivery may improve glycemic
outcomes in young children with type 1 diabetes. The efficacy and safety of initiating a …

Background Currently available semiautomated insulin-delivery systems require
individualized insulin regimens for the initialization of therapy and meal doses based on …

Background The possible advantage of hybrid closed-loop therapy (ie, artificial pancreas)
over sensor-augmented pump therapy in very young children with type 1 diabetes is …

Objective To provide evidence-based recommendations regarding the use of advanced
technology in the management of persons with diabetes mellitus to clinicians, diabetes-care …

OBJECTIVE Advances in diabetes technology have transformed the treatment paradigm for
type 1 diabetes, yet the burden of disease is significant. We report on a pivotal safety study …

Advances in diabetes technologies have enabled the development of automated closed-
loop insulin delivery systems. Several hybrid closed-loop systems have been …

Despite over 100 years of insulin therapy, glycemia remains suboptimal for many individuals
living with diabetes. Data from international diabetes registries highlight that most youth with …